Equities research analysts predict that MedAvail Holdings, Inc (NASDAQ:MDVL) will post earnings per share of ($0.29) for the current quarter, Zacks reports. Zero analysts have provided estimates for MedAvail’s earnings. MedAvail reported earnings per share of ($0.84) in the same quarter last year, which suggests a positive year over year growth rate of 65.5%. The business is scheduled to announce its next quarterly earnings results on Wednesday, August 4th.
According to Zacks, analysts expect that MedAvail will report full year earnings of ($1.12) per share for the current fiscal year. For the next year, analysts anticipate that the firm will report earnings of ($0.93) per share. Zacks Investment Research’s earnings per share averages are an average based on a survey of research analysts that cover MedAvail.
MedAvail (NASDAQ:MDVL) last issued its quarterly earnings results on Tuesday, March 30th. The company reported ($0.57) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.43) by ($0.14). MedAvail had a negative return on equity of 70.13% and a negative net margin of 291.15%. The business had revenue of $3.10 million for the quarter.
Hedge funds and other institutional investors have recently modified their holdings of the business. Burleson & Company LLC bought a new stake in MedAvail during the 1st quarter valued at $32,000. Morgan Stanley purchased a new position in shares of MedAvail in the 1st quarter valued at $63,000. Squarepoint Ops LLC purchased a new position in shares of MedAvail in the 4th quarter valued at $160,000. Geode Capital Management LLC purchased a new position in shares of MedAvail in the 1st quarter valued at $184,000. Finally, BBR Partners LLC purchased a new position in shares of MedAvail in the 4th quarter valued at $229,000. 83.60% of the stock is owned by institutional investors and hedge funds.
Shares of MDVL stock traded up $0.26 on Thursday, reaching $14.00. 28,551 shares of the company’s stock were exchanged, compared to its average volume of 78,193. MedAvail has a 52 week low of $9.00 and a 52 week high of $46.20. The company has a market cap of $455.29 million, a PE ratio of -5.22 and a beta of 1.18. The business has a fifty day moving average of $12.91.
MedAvail Holdings, Inc operates as a technology enabled pharmacy company that embeds automated pharmacy services directly into clinics and other points of care through its proprietary technology. The company provides turnkey services through its proprietary robotic dispensing platform, the MedAvail MedCenter, and home delivery operations.
Further Reading: What are some reasons analysts would give stocks a buy rating?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for MedAvail Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedAvail and related companies with MarketBeat.com's FREE daily email newsletter.